中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [17]
西安光学精密机械研究... [2]
计算技术研究所 [1]
采集方式
OAI收割 [20]
内容类型
期刊论文 [18]
专利 [2]
发表日期
2023 [4]
2022 [1]
2021 [6]
2020 [4]
2019 [3]
2015 [2]
更多
学科主题
筛选
浏览/检索结果:
共20条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Structure-based drug discovery of novel fused- pyrazolone carboxamide derivatives as potent and selective AXL inhibitors
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4918-4933
作者:
Fang, Feifei
;
Dai, Yang
;
Wang, Hao
;
Ji, Yinchun
;
Liang, Xuewu
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2024/01/26
derivatives
Antitumor drug development
Potential AXL inhibitor
Antitumor activity
Structure-based drug design
Fused-pyrazolone carboxamide
Rapid Access to Polysubstituted Tetrahydrocarbazol-4-ones via Sequential Selective C-H Functionalization from N-Nitrosoanilines
期刊论文
OAI收割
CHINESE JOURNAL OF CHEMISTRY, 2023, 页码: 1957-1962
作者:
Li, Chan
;
Yang, Yanchen
;
Fang, Feifei
;
Liu, Chaoyi
;
Li, Chunpu
  |  
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2023/10/17
C-H activation
Cross dehydrogenative coupling
Rhodium catalysis
Iridium catalysis
Alkenylation
Amaidiation
Heteroarylation
Rh(III)-Catalyzed Synthesis of Substituted Isoindoles through a Direct C-H Activation/[4+1] Annulation and Acyl Migration Cascade of Oxadiazolones with Diazo Compounds
期刊论文
OAI收割
ORGANIC LETTERS, 2023, 页码: 5
作者:
Yang, Xiaohao
;
Ren, Hairu
;
Zhou, Shengbin
;
Li, Chunpu
;
Liu, Chaoyi
  |  
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2023/10/17
Structural Optimization of Fibroblast Growth Factor Receptor Inhibitors for Treating Solid Tumors
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 5, 页码: 3226-3249
作者:
Li, Chunpu
;
Dai, Yang
;
Kong, Xiangtai
;
Wang, Bao
;
Peng, Xia
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2024/03/27
Discovery of Pyrazolo[3,4-d]pyridazinone Derivatives as Selective DDR1 Inhibitors via Deep Learning Based Design, Synthesis, and Biological Evaluation
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 1, 页码: 103-119
作者:
Tan, Xiaoqin
;
Li, Chunpu
;
Yang, Ruirui
;
Zhao, Sen
;
Li, Fei
  |  
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2022/06/15
5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 222, 页码: 19
作者:
Wang, Shuni
;
Yang, Hong
;
Su, Mingbo
;
Lian, Fulin
;
Cong, Zhanqing
  |  
收藏
  |  
浏览/下载:74/0
  |  
提交时间:2021/11/04
NSD2
Methyltransferase
HTS
Multiple myeloma
5-Aminonaphthalene derivatives
Inhibitor
Identification of Novel Fused Heteroaromatics-Based MALT1 Inhibitors by High-Throughput Screening to Treat B Cell Lymphoma
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 13, 页码: 9217-9237
作者:
Liang, Xuewu
;
Sun, Chenxia
;
Li, Chunpu
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2021/08/17
MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies
期刊论文
OAI收割
MEDICINAL RESEARCH REVIEWS, 2021, 页码: 35
作者:
Liang, Xuewu
;
Cao, YiChun
;
Li, Chunpu
;
Yu, Haolan
;
Yang, Chenghua
  |  
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2021/05/24
DLBCL
MALT lymphoma
MALT1
MALT1 inhibitors
NF‐
κ
B pathway
Discovery of 5-Benzylidene-2-phenyl-1,3-dioxane-4,6-diones as Highly Potent and Selective SIRT1 Inhibitors
期刊论文
OAI收割
ACS MEDICINAL CHEMISTRY LETTERS, 2021, 卷号: 12, 期号: 3, 页码: 397-403
作者:
Li, Chunpu
;
Hu, Sha-Sha
;
Yang, Lisheng
;
Wang, Min
;
Long, Jian-Dong
  |  
收藏
  |  
浏览/下载:75/0
  |  
提交时间:2021/05/24
SIRT1
inhibitor
structure-activity relationship
interaction
deacetylase
Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2021, 卷号: 11, 期号: 3, 页码: 781-794
作者:
Wu, Xiaowei
;
Dai, Mengdi
;
Cui, Rongrong
;
Wang, Yulan
;
Li, Chunpu
  |  
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2021/05/24
Tyrosine kinase
Covalent FGFR inhibitors
Virtual screening
Pyrazolo[3,4-d] pyridazinone
Structure-activity relationships
Antitumor efficacy